Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Polyps with Early-Onset Colorectal Cancer and Throughout Surveillance: Novel Clinical and Molecular Implications.
Perea García J, Arribas J, Cañete Á, García JL, Álvaro E, Tapial S, Narváez C, Vivas A, Brandáriz L, Hernández-Villafranca S, Rueda D, Rodríguez Y, Pérez-García J, Olmedillas-López S, García-Olmo D, Cavestro GM, Urioste M, Goel A, González-Sarmiento R. Perea García J, et al. Cancers (Basel). 2019 Nov 29;11(12):1900. doi: 10.3390/cancers11121900. Cancers (Basel). 2019. PMID: 31795313 Free PMC article.
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial.
Fernández-Mateos J, Pérez-García J, Seijas-Tamayo R, Mesía R, Rubió-Casadevall J, García-Girón C, Iglesias L, Carral Maseda A, Adansa Klain JC, Taberna M, Vazquez S, Gómez MA, Del Barco E, Ocana A, González-Sarmiento R, Cruz-Hernández JJ. Fernández-Mateos J, et al. Sci Rep. 2020 Oct 6;10(1):16634. doi: 10.1038/s41598-020-72927-2. Sci Rep. 2020. PMID: 33024167 Free PMC article.
[Patients with clinical criteria for Lynch syndrome with and without mutations in DNA repair genes (MLH1 and MSH2). A challenge for the clinician].
Seijas Tamayo R, Martín Gómez T, Pérez García J, Macías Álvarez L, Sánchez Barba M, Castro Marcos E, Sánchez Tapia EM, González Sarmiento R, Cruz Hernández JJ. Seijas Tamayo R, et al. Med Clin (Barc). 2011 Jul 9;137(4):166-70. doi: 10.1016/j.medcli.2011.03.017. Epub 2011 May 23. Med Clin (Barc). 2011. PMID: 21601892 Spanish.
Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.
García-Tuñón I, Vuelta E, Lozano L, Herrero M, Méndez L, Palomero-Hernandez J, Pérez-Caro M, Pérez-García J, González-Sarmiento R, Sánchez-Martín M. García-Tuñón I, et al. Mol Biol Rep. 2020 Feb;47(2):1381-1391. doi: 10.1007/s11033-019-05214-7. Epub 2019 Dec 12. Mol Biol Rep. 2020. PMID: 31833031
[Locoregional treatment of carcinoma epidermoid of the maxillary sinus].
Pérez García JE, Cuesta Gil M, López de Atalaya FJ, Concejo Cútoli C, Fernández-Alba Luengo J, Salmerón Escobar JI, Navarro Vila C. Pérez García JE, et al. Acta Otorrinolaringol Esp. 2000 Aug-Sep;51(6):495-500. Acta Otorrinolaringol Esp. 2000. PMID: 11142785 Spanish.
A practitioner's views on fluid therapy in calves.
Perez Garcia J. Perez Garcia J. Vet Clin North Am Food Anim Pract. 1999 Nov;15(3):533-43. doi: 10.1016/s0749-0720(15)30162-6. Vet Clin North Am Food Anim Pract. 1999. PMID: 10573810 Review.
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.
Llombart-Cussac A, Pérez-Garcia JM, Ruiz Borrego M, Tolosa P, Blanch S, Fernández-Ortega A, Urruticoechea A, Blancas I, Saura C, Rojas B, Bermejo B, Ponce Lorenzo J, Gion M, Cortez-Castedo P, Llabres E, Galve E, Cueva JF, López A, Alonso-Romero JL, González-Santiago S, Martínez de Dueñas E, Ciruelos E, Martrat G, Gener P, Alcalá-López D, Sampayo-Cordero M, Gómez-Peralta F, Cortés J. Llombart-Cussac A, et al. Among authors: perez garcia jm. EClinicalMedicine. 2024 Apr 11;71:102520. doi: 10.1016/j.eclinm.2024.102520. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38638399 Free PMC article.
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.
Franco-Mateos E, Souza-Egipsy V, García-Estévez L, Pérez-García J, Gion M, Garrigós L, Cortez P, Saavedra C, Gómez P, Ortiz C, Cruz VL, Ramos J, Cortés J, Vega JF. Franco-Mateos E, et al. Among authors: perez garcia j. Int J Mol Sci. 2024 Apr 1;25(7):3940. doi: 10.3390/ijms25073940. Int J Mol Sci. 2024. PMID: 38612751 Free PMC article.
256 results